When Ben Brown, research assistant professor of chemistry, thinks about the opioid epidemic, he views the problem on a molecular level.
#WCLC24 roundup: ArriVent thinks its drug can fill Tagrisso’s gaps; Boehringer, Bayer’s data in HER2-mutated lung cancer
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
September 10, 2024